APA (7th ed.) Citation

Bagatell, R., London, W. B., Wagner, L. M., Voss, S. D., Stewart, C. F., Maris, J. M., . . . Cohn, S. L. (2011). Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study. Journal of clinical oncology, 29(2), 208-213. https://doi.org/10.1200/JCO.2010.31.7107

Chicago Style (17th ed.) Citation

Bagatell, Rochelle, Wendy B. London, Lars M. Wagner, Stephan D. Voss, Clinton F. Stewart, John M. Maris, Cynthia Kretschmar, and Susan L. Cohn. "Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study." Journal of Clinical Oncology 29, no. 2 (2011): 208-213. https://doi.org/10.1200/JCO.2010.31.7107.

MLA (9th ed.) Citation

Bagatell, Rochelle, et al. "Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study." Journal of Clinical Oncology, vol. 29, no. 2, 2011, pp. 208-213, https://doi.org/10.1200/JCO.2010.31.7107.